Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints

Conclusions:
The present study showed that reductions in the risks of relapse and severe relapse differed among patients who were initially treated with azathioprine, MMF, and rituximab.

Source: Multiple Sclerosis - March 7, 2016 Category: Neurology Authors: Jeong, I. H., Park, B., Kim, S.-H., Hyun, J.-W., Joo, J., Kim, H. J. Tags: Original Research Papers Source Type: research